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Abstract
Background: For women seeking permanent contraception, there are a variety of options available including surgical
techniques such as tubal ligation or bilateral salpingectomy, in-clinic procedures such as hysteroscopic techniques
using micro-inserts, or the levonorgestrel-releasing intrauterine contraceptive. Despite the various methods available for
women who are seeking permanent contraception, there is not a review or decision-making tool that systematically
brings together outcomes related to effectiveness, tolerability, adverse effects, non-contraceptive benefits, recovery, or
accessibility: all of which are important for shared decision-making between patients and health care providers.
Methods: We registered our protocol [on Prospero: CRD42016038254] following PRISMA guidelines. A search strategy
was created in collaboration with a librarian, and three databases (EMBASE, PubMed, Web of Science) will be searched
along with secondary screening of relevant articles. A third reviewer will adjudicate any discrepancies. Data will be
extracted independently according to population, intervention, comparison, outcomes (PICOS); length of follow-up;
and funding. Articles will be assessed for bias using the Newcastle-Ottawa Scale and the Cochrane Collaboration tool. If
appropriate, a network meta-analysis will be conducted to rank and analyze each method according to each objective.
If heterogeneity between studies is too high or it is not possible to conduct a network meta-analysis, a narrative
analysis of the study results will be provided.
Discussion: Clinicians and their patients seeking permanent contraception have several options, yet we were unable
to find a systematic review or decision support tool helping to facilitate shared decision-making. This systematic review
can inform patients, providers, and health policy decision-makers about which options of permanent contraception will
meet different reproductive goals according to various outcomes, which can lead to better health, social, economic,
and mental well-being for reproductive age women. This can also aid our understanding of resulting costs to the
health care system.
Systematic review registration: PROSPERO CRD42016038254
Keywords: Shared decision-making, Levonorgestrel intrauterine system, Tubal ligation, Salpingectomy, Tubal occlusion,
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Introduction
Rationale
Continuing high rates of unintended pregnancy in
Canada suggest that there is a discrepancy between
available methods of contraception and contraception
use and compliance. Literature suggests that when pa-
tients are involved in treatment plans through shared
decision-making, there is better adherence and thus bet-
ter outcomes [1]. Therefore, there is a significant need
to involve women in choosing an appropriate method of
contraception through shared decision-making, so that
they are matched with a method that meets their and
their families’ reproductive goals. For some women who
are finished having children or who do not wish to have
children, permanent contraception or long-term contra-
ception methods may be an appropriate choice.
Trends worldwide and across North America illustrate
growing numbers of women utilizing permanent contra-
ceptive methods [2]. In the USA, approximately 290,000
cases of interval sterilization occur annually, and
permanent contraception is now used by 25% of women
of reproductive age (15–44 years) in the USA who are
using contraception [3]. While permanent contraception
continues to be a popular method of choice among
women who do not wish to have children, recent trends
have shown an increase in the use of the intrauterine de-
vice (IUD) across almost all populations of women using
contraception in the USA [4]. Similarly in Canada, per-
manent contraception is the fourth most commonly
used method among women who use contraception [5].
There are several options available for women seeking
permanent contraception. Laparoscopic tubal ligation
and hysteroscopic tubal occlusion are among the most
common methods of surgical permanent contraceptive
methods [6]. Laparoscopic tubal ligation is a surgical
procedure in which fallopian tubes are cut, sealed, or
burned with an electrical current through a small ab-
dominal incision, preventing the movement of the egg
from the ovary to the uterus for fertilization and im-
plantation. The procedure is done under a general or
local anesthetic and can be done immediately following
a vaginal or cesarean delivery [7]. Approximately 5.5
pregnancies will occur out of every 1000 tubal ligations
performed [8].
Hysteroscopic tubal occlusion (commonly known as
Essure® or Adiana®) is a surgical procedure in which
small metal clips or “microinserts” are inserted into the
fallopian tubes with a catheter and held in place by
stainless steel inner and nickel-titanium outer coils.
These coils encourage tissue growth, which after
approximately 3 months occludes the fallopian tubes,
preventing sperm from reaching the egg and the egg
from reaching the uterus. Placement of the clips is typic-
ally performed using a hysteroscopic approach, under
local anesthetic [9]. It takes approximately 3 months for
occlusion to occur. During this time, a woman is
required to use alternate contraceptive methods. A
post-procedure confirmation through a hysterosalpingo-
gram (HSG) exam is required before a woman can dis-
continue alternative methods and the procedure is
considered complete [10]. In an HSG exam, iodine-
based dye is placed through the cervix, and X-rays are
taken to determine full occlusion of the fallopian tubes,
thus completion of the procedure. Failure rates are re-
ported to be between 0.2 and 0.5% based on results after
a successful HSG exam [11].
In British Columbia, Canada, recent trends regarding
permanent contraception are shifting towards the use of
the bilateral salpingectomy. The increased frequency of
salpingectomy is largely due to emerging theoretical
evidence suggesting that epithelial ovarian cancers may
originate from the fallopian tube, and removing the fal-
lopian tubes may play a role in preventing ovarian can-
cer [12]. A British Columbian regional cancer initiative
in 2012 encouraged surgeons to consider performing an
opportunistic salpingectomy in place of tubal ligation for
women seeking permanent contraception. The regional
ovarian cancer initiative proposing the increase in up-
take of bilateral salpingectomy for prophylactic reasons
has stemmed a debate on whether the procedure should
be adopted based on the theoretical evidence of a reduc-
tion in ovarian cancer or whether physicians are obli-
gated to wait until there is sufficient evidence. The
debate centers around whether salpingectomies should
be considered alongside other methods of permanent
contraception such as tubal ligation or whether it should
be performed within the context of a clinical trial as a
means of gathering evidence first [13]. With a significant
uptake of bilateral salpingectomies being performed for
permanent contraception (from 0.5% in 2011 to 33% in
2015 in British Columbia alone), it is important to
understand how the procedure compares to and fits
alongside other available options [12, 14].
Additionally, long-acting reversible contraceptives may
also be appropriate for women seeking permanent or
long-term contraception. There are two types of intrauter-
ine devices which act as long-acting, reversible methods of
contraception available for women in North America:
Copper T intrauterine device (IUD) and the levonorgestrel-
releasing intrauterine contraceptive (LNG-IUC). The Cop-
per T-IUD is a copper-wrapped, polyethylene T-shaped
device. Release of copper into the uterine cavity creates a
foreign-body reaction resulting in an inhabitable environ-
ment for sperm transport or fertilization [15]. The
LNG-IUC is also a polyethylene T-shaped device, infused
with 52mg of levonorgestrel instead of copper. As levonor-
gestrel is administered into the uterine cavity, uterine lining
is thinned and at the same time cervical mucous thickens
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to block sperm entry. While both intrauterine devices are
effective, the LNG-IUC has a higher effectiveness rate at
0.1 compared to 0.8 pregnancies per 100 women [15]. With
a higher rate of pregnancy prevention than tubal occlusion,
the LNG-IUC is underutilized in conversations about per-
manent contraception and arguably should be included in
the decision-making process when considering methods of
permanent and/or long-acting contraception [16].
With new and innovative methods of permanent
contraception being introduced, it is important that
health policy and guidelines for contraceptive techniques
and methods reflect current evidence. Women should be
counseled on all available options, including the associ-
ated potential risks and benefits, so as to make the best
decision to meet their specific reproductive goals. While
there is a range of options available to women seeking
permanent and/or long-term contraception, there yet re-
mains to be a decision support tool or a systematic re-
view comparing available evidence for existing options.
We aim to perform a systematic review and network
meta-analysis comparing hysteroscopic tubal occlusion
(HTO), laparoscopic tubal ligation (LTL), bilateral
salpingectomy (BS), and the levonorgestrel-releasing
intrauterine contraceptive (LNG-IUC) on effectiveness,
adverse effects, tolerability, and non-contraceptive bene-
fits for women, and health system cost-effectiveness in
high-resource countries.
Objectives
This research aims to fill a gap in the literature compar-
ing the different methods of reversible long-acting and/
or permanent contraception available and, in doing so,
inform current policy guidelines regarding female per-
manent contraception alternatives. This can have further
implications for areas that do not have the capacity to
perform invasive or surgical techniques, providing
non-surgical alternatives for women seeking permanent
contraception. Understanding the associated relative
risks and benefits has the ability to facilitate shared
decision-making between patients and physicians, as a
way to best meet their patients’ needs and values.
Specific aims include:
1. Assessing the clinical risks and benefits of four
contraceptive methods for women seeking
permanent contraception: tubal occlusion, tubal
ligation, LNG-IUC, and opportunistic
salpingectomy;
2. Use this information and existing literature to
compare these four methods according to
effectiveness, adverse effects, tolerability, non-
contraceptive benefits, patient recovery, and
accessibility;
3. Create tools that will be useful to inform health
policy and clinical guidelines, and promote shared
decision-making among patients and physicians
Population
This systematic review is focused on reproductive age
women (ages 15–49 years) living in high-resource coun-
tries as defined by the World Bank Country and Lending
Groups [17] who are seeking permanent contraception.
Intervention/comparison:
 Hysteroscopic tubal occlusion with microinserts
 Laparoscopic tubal ligation
 Levonorgestrel-releasing intrauterine contraceptive
 Bilateral salpingectomy
Primary outcomes:
 Effectiveness is defined as the typical use rate at
which the method prevents pregnancy: the inherent
efficacy of the contraceptive method, and the
correct application [1]. It may be reported as a
percentage, or number of pregnancies reported
per sample size.
 Adverse effects are defined as an undesired harmful
effect resulting from the method of contraception
being employed—hysteroscopic tubal occlusion,
laparoscopic tubal ligation, LNG-IUC, and opportunis-
tic salpingectomy. Adverse effects include but are not
limited to prolonged pain in lower abdomen; minor
complications such as infection and wound separation;
and major complications including heavy blood loss,
anesthesia problems, injury during surgery/insertion,
need for larger incision.
 Tolerability is defined as the ability of a patient to
withstand any adverse effects and will be measured
as the number of women who successfully used the
procedure/treatment and did not require removal
of the LNG-IUC/microinsert clips or additional pro-
cedures to attend to any adverse effects that may have
resulted from the respective procedure.
 Non-contraceptive benefits are defined as effects
that are positive for a woman apart from
effectiveness at preventing pregnancy including,
but not limited to, decreased risk of ovarian cancer,
alleviation of acne, relief of dysmenorrhea and/or
menorrhagia, or decreased associated infections or
diseases such as pubic inflammatory disease (PID).
 Patient recovery is defined as the time reported for
a woman to recover, or to return to her typical state
of well-being, after the procedure. Patient recovery
includes, but is not limited to, post-procedure pain
reported, reported satisfaction, and recovery time,
including length of hospital stay.
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 Accessibility of each treatment is measured in terms
of the out of pocket costs for the procedure,
eligibility or ineligibility for each procedure, wait
times, and the locations where the procedure can be
performed (i.e., hospitals, clinics).
Secondary outcomes include:
 Length of the procedure
 Number of follow-ups needed to ensure that the
method is complete or is required for safety
monitoring
 Who is eligible or not eligible for each respective
method
 Cost to health care system for each respective
method
Methods
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines will be followed [18].
Eligibility criteria
Inclusion criteria included:
 Studies involving samples of women of reproductive
age (15–49 years)
 Study designs include case-control, comparative
observational studies (retrospective and prospective),
and single or multi-centered randomized controlled
trials evaluating pairwise comparisons related to
any of the four methods involved in the review (hys-
teroscopic tubal occlusion, laparoscopic tubal
ligation, levonorgestrel-releasing intrauterine
contraceptive, bilateral salpingectomy, and/or a
control)
 Studies evaluating outcomes related to effectiveness,
adverse effects, tolerability, non-contraceptive bene-
fits, patient recovery, and financial accessibility as
defined above
 Studies performed in high-income countries as
defined by the World Bank Country and Lending
Groups [17]
 All articles must be peer reviewed and published in
English.
 No date restrictions.
 Electrocoagulation, tubal rings, Filshie clips, and the
Pomeroy technique are all considered as “tubal
ligation” as several included studies did not
differentiate between which laparoscopic technique
was used. Essure, Adiana, and surgical contraception
techniques using microinserts were combined into
one treatment under ‘tubal occlusion.’ Bilateral
salpingectomy, opportunistic salpingectomy,
prophylactic salpingectomy, and tubectomy were
combined under “salpingectomy.”
Information sources and search
Relevant articles were identified through a search of
EMBASE, Web of Science, and PubMed (Medline)
using a combination of MeSH terms and key words
related to hysteroscopic tubal occlusion, laparoscopic
tubal ligation, levonorgestrel-releasing intrauterine
contraceptive (LNG-IUC), and opportunistic salpingec-
tomy after consultation with a reference librarian
familiar with systematic reviews. Copies of the search
strategies can be found at http://med-fom-cart-grac.
sites.olt.ubc.ca/files/2016/05/Search-Strategies-Librar-
ian-edit.docx.
Study records
Screening for eligible studies
Throughout the review process, articles will be stored in
the Mendeley Desktop Manager (Version 1.17.17, Men-
deley Ltd., 2017) [19]. Duplicates will be removed using
the duplication tool. Reviewers RG and BV will review
titles and abstracts, and obtain full text for any articles
deemed to be relevant. Reviewers will then apply the in-
clusion criteria to come up with a list of eligible articles.
All studies, which upon inspection of the full text do not
merit inclusion, will be detailed in an “Excluded Studies”
table with reasons for exclusion. Any disagreements will
be adjudicated by author WVN.
Data extraction and management
RG created the initial data extraction form. The data ex-
traction form will then be pilot-tested on a randomly se-
lected subset of studies and will be modified according to
feedback and outcomes. This will ensure that the data ex-
traction form is providing a comprehensive method of col-
lecting key findings for this review. Data will be extracted
from each study to meet the inclusion criteria including
population, intervention, comparisons, outcomes, and
study design (PICOS); follow-up period; biases; and fund-
ing source. Reviewers RG and BV will perform data
extraction independently, and discrepancies will be dis-
cussed and consulted with third reviewer WVN.
Risk of bias in individual studies
Each individual study will be evaluated for risk of bias
according to the Newcastle-Ottawa Scale (NOS) [20] for
assessing the quality of non-randomized studies in
meta-analyses, and the Cochrane risk of bias tool [21]
for randomized controlled trials with a focus on study
design, sampling strategy, appropriateness of analytical
methods used, and other biases that may be present.
The NOS tool is a widely used and well-established tool
for assessing the risk of bias in observational studies and
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has been previously validated for case-control and longi-
tudinal studies [20]. The Cochrane tools are domain-
based evaluations rather than a scaled or checklist evalu-
ation. Assigning numbers and weighting different items
on a scale can be difficult to justify: domain-based adjudi-
cation allows for critical assessment and a further interro-
gation into internal validity, and the extent to which
inclusion and exclusion criteria were clearly described and
implemented [21]. The risk of bias for each included art-
icle will be presented in a “Risk of Bias” table according to
Ottawa-Newcastle and Cochrane standards.
Data synthesis
If appropriate, a network meta-analysis will be con-
ducted using statistical software following the Cochrane
Methods network meta-analysis toolkit. The study data
will be quantitatively synthesized by computing direct
estimates between comparisons, indirect estimates for
comparisons, pooling the indirect and direct compari-
sons to create the mixed estimate for comparisons, and
checking the consistency between the direct and indirect
estimates following the Bucher method [22]. Baseline
characteristics, weighted means, successful placement or
successful outcome, and odds ratio (OR) or risk ratio (RR)
according to individual sample size will be used. I2 (95%
confidence interval) statistic for each meta-analysis will be
estimated to assess heterogeneity across studies. As per
the Cochrane Handbook, we will consider heterogeneity
to be low if I2 = 0–25%, moderate if I2 = 25–50%, and
substantial if I2 > 50% [21].
Data will be summarized by abstracting relevant data,
developing data tables, and synthesizing the literature.
The feasibility of completing a quantitative analysis (net-
work meta-analysis) will depend on the available literature,
conceptual homogeneity, and completeness of reporting
results that are necessary for completing a quantitative
analysis. In the case that heterogeneity between studies is
too high or is not possible to conduct a network
meta-analysis, we will provide a narrative analysis of the
study results. Patterns of effects, similarities, and differ-
ences between studies will be presented according to the
Cochrane Consumers and Communication Review Group
guidelines [23]. To maintain transparency about selective
reporting, any deviations from our protocol will be
reported in the final review under a “differences between
protocol and review section” with explanations for any
deviation.
Presenting and reporting results
Preferred Reporting Items for Systematic Reviews and
Network Meta-Analyses (PRISMA) statement will be
followed [24] including PRISMA “diagram to illustrate
the process of selecting eligible studies.”
Discussion
Previous research has provided updates on different op-
tions of methods of permanent contraception; however, to
date, there is not a study that systematically brings to-
gether the major methods of permanent contraception in
a comparison format with other methods of permanent
and/or long-acting forms of contraception. A systematic
review analysis comparing the benefits and risks of hyster-
oscopic tubal occlusion using microinserts, laparoscopic
tubal ligation, the LNG-IUC, and opportunistic salpingec-
tomy for reproductive-aged women seeking permanent
and/or long-acting contraception will provide an
evidence-based tool to inform regional health guidelines
in contraceptive counseling and contraceptive methods.
The document resulting from this research will inform pa-
tients, providers, and health policy decision-makers about
which methods of permanent contraception will meet dif-
ferent reproductive goals, according to various outcomes.
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